Internal Medicine, Gastroenterology · Scottsdale, AZ
NPI
1316920010
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
20401 N 73rd St, Suite 275
Scottsdale, AZ, 85255
Phone (480) 945-2321
Groups this clinician bills Medicare through
Medicare paid, 2024
$141K
1,370 services
Medicare patients, 2024
821
Average age 75
Drug cost, 2024
$1.3M
1,606 prescriptions
Company payments, 2025
$129
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stuart L Triester was code 99214 (office e&m - established), 262 times for 221 patients. In total Stuart L Triester billed 1,370 services in 40 codes, and Medicare paid $141K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-08-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 262 | 221 | $90.36 | $24K |
| 45385 Colonoscopy - Lesion Removal | Facility | 176 | 176 | $180.99 | $32K |
| 45380 Lower GI Endoscopy - Other | Facility | 176 | 176 | $91.07 | $16K |
| 43239 Upper GI Endoscopy | Facility | 172 | 171 | $60.88 | $10K |
| 99222 Hospital E&M - Initial | Facility | 109 | 107 | $95.94 | $10K |
| 99204 Office E&M - New | Office | 67 | 67 | $109.53 | $7,339 |
| 99232 Hospital E&M - Subsequent | Facility | 57 | 51 | $60.17 | $3,429 |
| 43249 Upper GI Endoscopy | Facility | 41 | 41 | $87.44 | $3,585 |
| 43235 Upper GI Endoscopy | Facility | 36 | 36 | $68.26 | $2,457 |
| 45378 Lower GI Endoscopy - Other | Facility | 35 | 35 | $133.23 | $4,663 |
| 99213 Office E&M - Established | Office | 34 | 32 | $61.69 | $2,097 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 34 | 34 | $170.69 | $5,803 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 30 | 30 | $173.77 | $5,213 |
| 99215 Office E&M - Established | Office | 26 | 25 | $133.79 | $3,478 |
| 45331 Lower GI Endoscopy - Other | Facility | 11 | 11 | $44.82 | $493 |
By year: 2022 $146K for 1,478 services; 2023 $139K for 1,419 services; 2024 $141K for 1,370 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stuart L Triester prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 314 prescriptions and refills. In total Stuart L Triester wrote 1,606 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 314 | 314 | 310 | $21K |
| Pantoprazole Sodium Generic | 240 | 522 | 90 | $2,247 |
| Famotidine Generic | 102 | 221 | 35 | $1,089 |
| Omeprazole Generic | 79 | 210 | 26 | $906 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 59 | 59 | 59 | $10K |
| Sodium Chloride 0.9 % Sodium Chloride | 54 | 54 | Under 11 | $995 |
| Prednisone Generic | 42 | 42 | 12 | $293 |
| Colestipol Hcl Generic | 39 | 89 | 17 | $3,842 |
| Sucralfate Generic | 39 | 51 | 14 | $1,191 |
| Amitriptyline Hcl Generic | 35 | 49 | Under 11 | $298 |
| Sulfasalazine Generic | 34 | 71 | Under 11 | $853 |
| Mesalamine Generic | 33 | 79 | 12 | $12K |
| Stelara Ustekinumab | 30 | 52 | Under 11 | $814K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 28 | 38 | 11 | $1,321 |
| Nortriptyline Hcl Generic | 27 | 43 | Under 11 | $252 |
Brand drugs: - claims; generic drugs: 1,239 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stuart L Triester $129 ($129 in general payments such as food, travel and fees) from 1 company. The largest payer was Boston Scientific Corporation with $129.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 2 | $129 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.